Debt-to-equity of Skye Bioscience, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Skye Bioscience, Inc. quarterly Debt-to-equity in % history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Skye Bioscience, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 20%, a 43% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Skye Bioscience, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 20% +6% +43% 31 Dec 2025
Q3 2025 13% -9% -40% 30 Sep 2025
Q2 2025 9.9% -29% -74% 30 Jun 2025
Q1 2025 11% -65% -86% 31 Mar 2025
Q4 2024 14% +378% 31 Dec 2024
Q3 2024 22% +349% 30 Sep 2024
Q2 2024 39% +238% 30 Jun 2024
Q1 2024 76% +366% 31 Mar 2024
Q4 2023 -364% +403% +53% 31 Dec 2023
Q3 2023 -327% -701% -187% 30 Sep 2023
Q2 2023 -200% -300% -298% 30 Jun 2023
Q1 2023 -289% -366% -477% 31 Mar 2023
Q4 2022 -767% -839% -1169% 31 Dec 2022
Q3 2022 374% +287% +328% 30 Sep 2022
Q2 2022 101% -53% -35% 30 Jun 2022
Q1 2022 77% -572% -88% 31 Mar 2022
Q4 2021 72% +490% 31 Dec 2021
Q3 2021 87% +490% 30 Sep 2021
Q2 2021 154% +276% 30 Jun 2021
Q1 2021 649% +775% 31 Mar 2021
Q4 2020 -418% -297% -246% 31 Dec 2020
Q3 2020 -402% -286% -247% 30 Sep 2020
Q2 2020 -122% -5.6% -4.8% 30 Jun 2020
Q1 2020 -126% -9.6% -8.3% 31 Mar 2020
Q4 2019 -121% +0.14% +0.11% 31 Dec 2019
Q3 2019 -116% -1.1% -0.95% 30 Sep 2019
Q2 2019 -117% -6.1% -5.6% 30 Jun 2019
Q1 2019 -116% -19% -20% 31 Mar 2019
Q4 2018 -121% -58% -93% 31 Dec 2018
Q3 2018 -115% -45% -65% 30 Sep 2018
Q2 2018 -111% -42% -62% 30 Jun 2018
Q1 2018 -97% -29% -42% 31 Mar 2018
Q4 2017 -63% +25% +29% 31 Dec 2017
Q3 2017 -70% +60% +46% 30 Sep 2017
Q2 2017 -68% +137% +67% 30 Jun 2017
Q1 2017 -68% +178% +72% 31 Mar 2017
Q4 2016 -88% +249% +74% 31 Dec 2016
Q3 2016 -130% +173% +57% 30 Sep 2016
Q2 2016 -206% 30 Jun 2016
Q1 2016 -246% 31 Mar 2016
Q4 2015 -337% 31 Dec 2015
Q3 2015 -303% 30 Sep 2015
Q2 2014 682% 31 Jul 2014
Q1 2014 910% 30 Apr 2014
Q4 2013 1196% 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.